Hormones and Asthma: How Puberty, Periods, Pregnancy, and Menopause Affect Your Breathing

If your asthma seems to flare at certain times of the month, worsened during pregnancy, or appeared for the first time around menopause, you are not imagining it. Hormonal changes have a direct, well-documented effect on airway inflammation and breathing. Understanding this connection is the first step toward better control.

At Advanced Asthma Clinic in Plantation, FL, Dr. Frank Hull takes a personalized approach to asthma care that accounts for hormonal influences. With over 20 years of experience in pulmonary medicine and access to advanced lung function testing, Dr. Hull helps patients identify hormonal patterns in their asthma and build treatment plans that address the full picture.

The Hormonal Connection: Why It Matters

Asthma affects men and women differently -- and hormones are the primary reason. Before puberty, asthma is more common in boys. After puberty, the pattern reverses: women are twice as likely as men to have asthma, experience more severe symptoms, and are hospitalized more often. This gender shift correlates directly with the rise and fluctuation of reproductive hormones.

The two key hormones involved are estrogen and progesterone. Both influence the immune system and airway function:

• Estrogen can promote certain types of airway inflammation, increase mucus production, and enhance the response of immune cells (particularly mast cells and eosinophils) in the lungs
• Progesterone generally has a relaxing effect on airway smooth muscle, but its rapid decline (as occurs before menstruation) can trigger rebound airway tightening
• Testosterone appears to have a protective effect, which may partly explain why adult men tend to have less severe asthma than women

Puberty: When Asthma Patterns Shift

Puberty is the first major hormonal transition that reshapes asthma risk. The changes are significant:

• Girls: Rising estrogen levels during puberty increase the prevalence and severity of asthma. Girls who begin menstruating earlier (before age 12) have a higher risk of developing asthma. Obesity during puberty further amplifies this risk through additional estrogen production from adipose tissue
• Boys: Increasing testosterone during puberty is associated with improvement in childhood asthma. Many boys who had asthma as children see significant improvement or even remission during adolescence

If your teenager's asthma is changing -- improving or worsening -- puberty-related hormonal shifts may be a factor. A re-evaluation of their asthma management plan, including updated lung function testing, can ensure their treatment keeps pace with their changing physiology.

Perimenstrual Asthma: The Monthly Pattern

Perimenstrual asthma (PMA) is one of the most common and under-recognized hormonal asthma patterns. It affects an estimated 19-40% of women with asthma and is characterized by worsening symptoms in the days before and during menstruation.

What Happens in the Cycle

The menstrual cycle has two main phases relevant to asthma:

• Follicular phase (days 1-14): Estrogen rises steadily. Most women report relatively stable asthma during this phase
• Luteal phase (days 14-28): Both estrogen and progesterone rise after ovulation, then drop sharply before menstruation. This hormonal decline -- particularly in the late luteal phase (days 24-28) -- is when PMA symptoms peak

Studies show that women with PMA experience a measurable decline in peak expiratory flow and FEV1 during the perimenstrual window. Emergency department visits for asthma are also significantly higher during this phase.

Who Is Most at Risk?

PMA is more common in women who have:

• Severe or poorly controlled baseline asthma
• Aspirin-sensitive asthma
• Higher body mass index (BMI)
• Longer menstrual cycles
• Dysmenorrhea (painful periods)

Tracking the Pattern

If you suspect your asthma worsens around your period, keep a symptom diary that tracks your cycle alongside your peak flow readings, rescue inhaler use, and symptom severity. Two to three months of data can reveal a clear hormonal pattern that guides treatment adjustments. Share this diary with your doctor at your next visit.

Pregnancy and Asthma: What to Expect

Pregnancy involves dramatic hormonal shifts -- rising estrogen and progesterone levels, along with changes in immune function and respiratory physiology. The impact on asthma follows a well-known pattern called the "rule of thirds":

• One-third of women improve -- rising progesterone can relax airway smooth muscle, and increased cortisol production during pregnancy has natural anti-inflammatory effects
• One-third stay the same -- no significant change in asthma severity
• One-third worsen -- typically peaking between weeks 24 and 36 of pregnancy, then improving in the final month

Why Asthma Control During Pregnancy Is Critical

Uncontrolled asthma during pregnancy poses real risks to both mother and baby:

• Increased risk of preeclampsia
• Preterm birth
• Low birth weight
• Increased risk of cesarean delivery

The evidence is clear: the risks of uncontrolled asthma far outweigh the risks of asthma medications during pregnancy. Most asthma medications -- including inhaled corticosteroids, short-acting beta-agonists, and certain biologics -- have well-established safety profiles during pregnancy. Budesonide is the most-studied inhaled corticosteroid in pregnancy and is considered first-line.

Never stop or reduce your asthma medications during pregnancy without consulting your physician. If you are pregnant or planning to become pregnant, schedule a review of your asthma management plan with Dr. Hull to ensure optimal control.

Breastfeeding

Most asthma medications are safe during breastfeeding. Only minimal amounts pass into breast milk, and the benefits of breastfeeding -- which may actually reduce your child's risk of developing asthma -- far outweigh theoretical medication concerns. Always consult your physician for personalized guidance.

Menopause and Asthma: A New Challenge

Menopause marks another significant hormonal transition that can substantially affect asthma. For some women, it brings asthma for the first time; for others, it worsens existing disease.

New-Onset Asthma at Menopause

Research shows that women who reach menopause -- whether naturally or surgically -- have an increased risk of developing asthma for the first time. The decline in estrogen and progesterone production alters immune regulation in the lungs, potentially unmasking a susceptibility that was previously balanced by hormonal influences.

Worsening of Existing Asthma

Women with pre-existing asthma may experience:

• More frequent exacerbations
• Reduced response to standard controller medications
• Increased airway hyperresponsiveness
• Greater symptom variability

Contributing Factors at Menopause

Several menopause-associated changes compound the hormonal effect on airways:

• Weight gain: Central obesity increases during menopause and is an independent risk factor for asthma severity. Adipose tissue produces inflammatory cytokines and additional estrogen metabolites that promote airway inflammation
• Gastroesophageal reflux (GERD): More common after menopause and a known asthma trigger
• Sleep disruption: Hot flashes and insomnia can worsen asthma control, as poor sleep increases inflammatory markers
• Decreased physical activity: Reduced exercise during menopause contributes to deconditioning and weight gain, further worsening asthma

Hormone Replacement Therapy (HRT) and Asthma

The relationship between HRT and asthma is complex. Some studies suggest that HRT may increase asthma risk in postmenopausal women, while others show improvement in airway function. The type of HRT (estrogen-only vs. combined estrogen-progesterone), route of administration, and individual patient factors all play a role. This is a decision that should be made collaboratively between you, your pulmonologist, and your gynecologist.

Managing Hormone-Related Asthma

Step-Up Therapy Around Triggers

For women with predictable perimenstrual flares, a "step-up" approach -- temporarily increasing controller medication dose during the high-risk phase of the cycle -- can be effective. For example, increasing the dose of an inhaled corticosteroid for 5 to 7 days around menstruation may prevent flares without requiring a permanently higher maintenance dose.

Leukotriene Modifiers

Leukotriene receptor antagonists such as montelukast may be particularly helpful in perimenstrual asthma, as leukotriene levels tend to rise during the late luteal phase. Some studies show improved symptoms and lung function when these medications are added premenstrually.

Biologic Therapy

For women with severe asthma that is poorly controlled despite standard therapy, biologic therapies targeting specific inflammatory pathways -- such as anti-IgE, anti-IL-5, or anti-IL-4/13 antibodies -- can provide significant improvement. These therapies address the underlying immune dysregulation rather than just managing symptoms, which can be especially beneficial when hormonal fluctuations amplify inflammation.

Lifestyle Strategies

• Maintain a healthy weight: Excess weight amplifies hormonal influences on airway inflammation. Even modest weight loss can improve asthma control
• Regular exercise: Consistent physical activity improves lung function and reduces inflammation. See our guide on exercising safely with asthma
• Manage co-triggers: Hormonal shifts often lower the threshold for other triggers. During high-risk hormonal periods, be extra vigilant about mold exposure, pet allergens, weather changes, and infection prevention
• Sleep hygiene: Prioritize 7-9 hours of quality sleep, which supports immune regulation and asthma control
• Stress management: Hormonal transitions often coincide with increased stress, which independently worsens asthma. Mindfulness, breathing exercises, and regular physical activity all help

When to See a Specialist

You should consult a pulmonary specialist like Dr. Frank Hull if you experience:

• Asthma that predictably worsens before your period, despite standard treatment
• New breathing symptoms that developed during or after pregnancy
• New-onset wheezing, coughing, or breathlessness around menopause
• Existing asthma that has become harder to control during a hormonal transition
• Uncertainty about whether your asthma medications are safe during pregnancy or breastfeeding

Hormonal asthma is real, common, and treatable. With the right diagnosis, monitoring, and a treatment plan that accounts for your hormonal patterns, you can achieve better control at every stage of life.

The Better Breathing Grant Program

If cost is a concern, Advanced Asthma Clinic's Better Breathing Grant program may help cover the cost of lung function testing and treatment. Ask our team about eligibility when you schedule your appointment.

Frequently Asked Questions

Can hormones make asthma worse?

Yes. Fluctuations in estrogen and progesterone can increase airway inflammation and reactivity. Many women notice asthma worsening before their period, during pregnancy, or around menopause. This is a well-documented medical phenomenon called hormone-related asthma, and it can be addressed with tailored treatment strategies.

Why does asthma get worse before my period?

Perimenstrual asthma affects up to 40% of women with asthma. The drop in estrogen and progesterone in the late luteal phase (the days before your period begins) can increase airway inflammation and smooth muscle reactivity, leading to more wheezing, coughing, and breathlessness. Tracking symptoms alongside your menstrual cycle can help confirm this pattern.

Is it safe to take asthma medication during pregnancy?

Yes -- most asthma medications are considered safe during pregnancy. Uncontrolled asthma poses greater risks to mother and baby than the medications used to treat it. Budesonide is the most-studied inhaled corticosteroid in pregnancy. Never stop or adjust your medications without consulting your physician.

Does menopause affect asthma?

Yes. Some women develop asthma for the first time during menopause, and those with existing asthma may experience worsening symptoms. The decline in estrogen can increase airway inflammation, and menopause-associated weight gain is an additional risk factor. Adjustments to your treatment plan can help maintain control through this transition.